IPO registrations (S-1, F-1) · Registrants

Midatech Pharma US Inc.

SEC CIK
919745 · filings on EDGAR ↗
Name on the registration
DARA BioSciences, Inc.
Former names
DARA BioSciences, Inc. (2008–2015); DARA BIOSCIENCES INC (2007–2008); POINT THERAPEUTICS INC (2002–2008); HMSR INC (2001–2002); HEMASURE INC (1996–2001)
Registration
Form S-1, first filed 2000-03-31, last 2014-05-22; 5 initial registrations, 14 amendments
Outcome
Final prospectus filed 2010-12-29; declared effective 2007-12-26
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
8601 SIX FORKS ROAD SUITE 160, Raleigh, NC 27615
EIN
04-3216862
EDGAR entity type
operating
Insiders and CEO pay
Midatech Pharma US Inc. on the corporate pages

Offering terms

Final price
$2.50 per share (424B4 filed 2010-12-29)
Shares sold
4,800
Gross proceeds
$12,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol DARA

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 54

FiledFormWhat it isName as filedEDGAR
2000-03-31S-1S-1 (registration)HEMASURE INC0000903112-00-000747 ↗
2000-05-31S-1/AS-1/A (amendment)HEMASURE INC0000903112-00-000905 ↗
2003-11-18S-1S-1 (registration)POINT THERAPEUTICS INC0001193125-03-083427 ↗
2003-12-19S-1/AS-1/A (amendment)POINT THERAPEUTICS INC0001193125-03-097009 ↗
2007-12-26EFFECTEFFECT (declared effective)POINT THERAPEUTICS INC9999999995-07-005082 ↗
2008-04-18EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-08-001124 ↗
2010-04-02S-1S-1 (registration)DARA BioSciences, Inc.0001193125-10-075962 ↗
2010-05-17S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-10-120902 ↗
2010-09-16S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-10-211462 ↗
2010-11-12S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-10-259063 ↗
2010-12-27EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-10-003710 ↗
2010-12-29S-1MEFS-1MEF (added securities)DARA BioSciences, Inc.0001193125-10-289448 ↗
2010-12-29424B4424B4 (final prospectus)DARA BioSciences, Inc.0001193125-10-289540 ↗
2011-04-19EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-11-001076 ↗
2012-02-23S-1S-1 (registration)DARA BioSciences, Inc.0001193125-12-074169 ↗
2012-03-13S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-12-112331 ↗
2012-03-26S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-12-131531 ↗
2012-04-04S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-12-149561 ↗
2012-04-06S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001193125-12-152403 ↗
2012-04-06EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-12-000965 ↗
2012-04-10424B1424B1 (final prospectus)DARA BioSciences, Inc.0001193125-12-157296 ↗
2012-04-26EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-12-001186 ↗
2012-04-26EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-12-001189 ↗
2013-04-10EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-13-000947 ↗
2013-05-01EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-13-001288 ↗
2013-05-01EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-13-001310 ↗
2013-12-16EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-13-003571 ↗
2013-12-23S-1S-1 (registration)DARA BioSciences, Inc.0001354488-13-006994 ↗
2014-02-26EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-14-000524 ↗
2014-02-26EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-14-000527 ↗
2014-03-20EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-14-000714 ↗
2014-04-18S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001354488-14-001972 ↗
2014-05-13S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001354488-14-002469 ↗
2014-05-14S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001354488-14-002566 ↗
2014-05-20S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001354488-14-002883 ↗
2014-05-22S-1/AS-1/A (amendment)DARA BioSciences, Inc.0001354488-14-002937 ↗
2014-05-29EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-14-001611 ↗
2014-06-02424B4424B4 (final prospectus)DARA BioSciences, Inc.0001354488-14-003063 ↗
2015-04-06EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-15-000788 ↗
2015-04-06EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-15-000791 ↗
2015-04-06EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-15-000795 ↗
2015-04-07EFFECTEFFECT (declared effective)DARA BioSciences, Inc.9999999995-15-000813 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003260 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003261 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003263 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003265 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003266 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003267 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003269 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003271 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003272 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003273 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003274 ↗
2015-12-14EFFECTEFFECT (declared effective)Midatech Pharma US Inc.9999999995-15-003276 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2010-11-12S-1/Aregistration statement4,000-Nasdaq DARA0primary document; shares headlinedocument ↗
2010-12-29424B4final prospectus$2.504,800$12,000Nasdaq DARA0primary document; price line, shares headline, proceeds computeddocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BARBERICH TIMOTHY JDirector32006
Benjamin Richard JDirector12006
CLAFLIN THOMAS M IIDirector12006
Pickering Larry GDirector12006
ROBLE DANIEL TDirector52006
WHELAN WILLIAM J JRDirector32006
UPRICHARD MARGARET JOfficerSVP, Chief Development Officer22006
DUFFY MICHAEL POfficerSVP, GC and Secretary12006
JONES BARRYOfficerSenior Vice President,Research12006
KIEPERT DONALD R JRDirector,OfficerChairman, President, CEO12006
SMALL RICHARD NOfficerSeniorVP,CFO,Treasurer12006person page Fuzzy
D'ALONZO THOMAS WDirector12008
Didsbury JohnOfficerChief Scientific Officer; COO and Chief Scientic Officer32008
Eichler Kurt MDirector12008person page Fuzzy
GORLIN STEVEDirector42008–2012
JORDAN HAMILTONDirector12008
McWhorter Stuart CDirector12008
Thomas John CDirector; OfficerCFO and Secretary52008–2012
FRANCO RICHARD ADirector,OfficerCEO; Chairman, President and CEO; President & CEO162008–2011
COCHRANE HAYWOOD DDirector192008–2015
Drutz DavidDirector; Director,OfficerCEO and CMO; Executive Chairman and CMO; President and CEO202008–2015
CAUWENBERGH GEERTDirector32008–2009
Rosar Ann AOfficerChief Accounting Officer; Vice President Finance62009–2012
Lieberman GailDirector152009–2015
CLEMENT CHRISTOPHER GDirector,OfficerChief Executive Officer; Chief Operating Officer; President; President and COO132012–2015
Tousley David L.OfficerActing Chief Financial Officer; CFO; Chief Financial Officer62012–2015
JAEGER STEPHEN ODirector42012–2013
Heady Timothy JamesDirector112012–2015
Richardson Paul JohnDirector82013–2015
Benharris DavidOfficerSenior Vice President22015

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2012-01-31DARA BioSciences, Inc.PharmaceuticalsIndefinite$1,448,928101

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationDARA BIOSCIENCES, INC.NCState business registriesEIN (EXACT, as the state registration reports it)
Federal award recipientMIDATECH PHARMA US INC.NCFederal spending (USAspending)name and state
Form D issuerDARA BioSciences, Inc.NCForm D private offeringsCIK (EXACT)
SEC filerMidatech Pharma US Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerMidatech Pharma US Inc.NCTrademarks (USPTO)name and state
Person pageKurt M EichlerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)
Person pageRichard N Small CpaPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NC first:

More with this interest.

In other datasets, the same topic (Health) in NC:

Interests: Pharmaceutical Preparations · Health